News

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration ...
But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the ...
WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...
Mifepristone, the abortion pill, is one of the most studied drugs on ... We don’t need another round of endless reviews. The evidence for medication abortion’s safety is overwhelming and crystal clear ...
A conservative think tank presses HHS Secretary Robert F. Kennedy Jr. to make good on his commitment to review the abortion pill.
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
Pressure is building on the Food and Drug Administration to reinstate safeguards on the abortion pill after a largest-of-its-kind study found the number of serious health scares far higher than ...
Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...